High Prevalence of Alterations in DNA Mismatch Repair Genes of Lynch Syndrome in Pediatric Patients with Adrenocortical Tumors Carrying a Germline Mutation on TP53
Carregando...
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Citação
CANCERS, v.12, n.3, article ID 621, 12p, 2020
Resumo
Adrenocortical cancer is a rare malignant neoplasm associated with a dismal prognosis. Identification of the molecular pathways involved in adrenal tumorigenesis is essential for a better understanding of the disease mechanism and improvement of its treatment. The aim of this study is to define the prevalence of alterations in DNA mismatch repair (MMR) genes in Lynch syndrome among pediatric patients with adrenocortical neoplasia from southern Brazil, where the prevalence of a specific TP53 germline mutation (p.Arg337His) is quite high. Thirty-six pediatric patients were retrospectively evaluated. Immunohistochemistry (IHC) for theMMR enzymes MLH1, MSH2, MSH6, and PMS2, as well as next-generation sequencing (NGS) were performed. For IHC, 36 pediatric tumors were tested. In all of them, the expression of all evaluated MMR proteins was well-preserved. For NGS, 35 patients with pediatric tumor were tested. Three patients (8.57%) with the TP53 p.Arg337His germline mutation presented pathogenic and likely pathogenic variants in the MMR genes (two in MLH1 and one in MSH6). The prevalence of alteredMMR genes among pediatric patients was elevated (8.57%) and higher than in colorectal and endometrial cancer cohorts. Pediatric patients with adrenocortical tumors should, thus, be strongly considered as at genetic risk for Lynch syndrome.
Palavras-chave
adrenal tumor, DNA mismatch repair, TP53
Referências
- Almeida MQ, 2008, J CLIN ENDOCR METAB, V93, P3524, DOI 10.1210/jc.2008-0065
- Bilimoria KY, 2008, CANCER, V113, P3130, DOI 10.1002/cncr.23886
- Boland CR, 1998, CANCER RES, V58, P5248
- BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0
- Caron O, 2012, B CANCER, V99, P99, DOI 10.1684/bdc.2011.1522
- Chang LS, 2018, APPL IMMUNOHISTO M M, V26, pE15, DOI 10.1097/PAI.0000000000000575
- Custodio G, 2012, MOL CELL ENDOCRINOL, V351, P44, DOI 10.1016/j.mce.2011.10.019
- Dackiw APB, 2001, WORLD J SURG, V25, P914, DOI 10.1007/s00268-001-0030-7
- Dillon JL, 2017, HUM PATHOL, V70, P121, DOI 10.1016/j.humpath.2017.10.022
- Dominguez-Valentin M, 2020, GENET MED, V22, P15, DOI 10.1038/s41436-019-0596-9
- Else T, 2014, ENDOCR REV, V35, P282, DOI 10.1210/er.2013-1029
- Fassnacht M., 2009, ADRENOCORTICAL CARCI, P23
- Fassnacht M., 2018, EUR J ENDOCRINOL, V179, pG1
- FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3
- Fishel R, 2015, J BIOL CHEM, V290, P26395, DOI 10.1074/jbc.R115.660142
- Giardiello FM, 2014, GASTROENTEROLOGY, V147, P502, DOI 10.1053/j.gastro.2014.04.001
- Heath JA, 2015, FAM CANCER, V14, P545, DOI 10.1007/s10689-015-9810-3
- Huang SC, 2014, J PEDIATR GASTR NUTR, V58, P144, DOI 10.1097/MPG.0000000000000179
- Jones JS, 2004, CLIN CANCER RES, V10, P5845, DOI 10.1158/1078-0432.CCR-03-0590
- Kebebew E, 2006, WORLD J SURG, V30, P872, DOI 10.1007/s00268-005-0329-x
- Kopanos C, 2019, BIOINFORMATICS, V35, P1978, DOI 10.1093/bioinformatics/bty897
- Kovacs ME, 2009, HUM MUTAT, V30, P197, DOI 10.1002/humu.20942
- Kratz CP, 2017, CLIN CANCER RES, V23, pE38, DOI 10.1158/1078-0432.CCR-17-0408
- Latronico AC, 2001, J CLIN ENDOCR METAB, V86, P4970, DOI 10.1210/jc.86.10.4970
- Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455
- LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S
- LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747
- Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146
- Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878
- LYNCH HT, 1966, ARCH INTERN MED, V117, P206, DOI 10.1001/archinte.117.2.206
- Mandelker D, 2015, EXP HEMATOL ONCOL, V4, DOI 10.1186/s40164-015-0026-x
- Wielandt AM, 2012, REV MED CHILE, V140, P1132, DOI 10.4067/S0034-98872012000900005
- McCarthy AJ, 2019, J PATHOL CLIN RES, V5, P115, DOI 10.1002/cjp2.120
- Moreira L, 2012, JAMA-J AM MED ASSOC, V308, P1555, DOI 10.1001/jama.2012.13088
- Palomaki GE, 2009, GENET MED, V11, P42, DOI 10.1097/GIM.0b013e31818fa2db
- PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251
- Pinto Emilia M., 2004, Arq Bras Endocrinol Metab, V48, P647, DOI 10.1590/S0004-27302004000500009
- Raymond VM, 2013, J CLIN ONCOL, V31, P3012, DOI 10.1200/JCO.2012.48.0988
- Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898
- Ries L, 2008, SEER CANC STAT REV 1
- Sandrini R, 1997, J CLIN ENDOCR METAB, V82, P2027, DOI 10.1210/jc.82.7.2027
- Smith TR, 2011, CARCINOGENESIS, V32, P1354, DOI 10.1093/carcin/bgr117
- Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854
- Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034
- Vasen HFA, 2005, JAMA-J AM MED ASSOC, V293, P2028, DOI 10.1001/jama.293.16.2028
- Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X
- VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699
- Wajchenberg BL, 2000, CANCER-AM CANCER SOC, V88, P711, DOI 10.1002/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W
- Young LC, 2007, CARCINOGENESIS, V28, P2131, DOI 10.1093/carcin/bgm153
Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/14
Artigos e Materiais de Revistas Científicas - LIM/15
Carregar mais Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/14
Artigos e Materiais de Revistas Científicas - LIM/15